Lehman & Derafelo Financial Resources’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$303K Hold
590
0.09% 88
2022
Q3
$268K Hold
590
0.08% 78
2022
Q2
$285K Hold
590
0.09% 81
2022
Q1
$290K Hold
590
0.08% 84
2021
Q4
$273K Hold
590
0.08% 84
2021
Q3
$220K Hold
590
0.07% 97
2021
Q2
$225K Hold
590
0.06% 111
2021
Q1
$212K Buy
+590
New +$190K 0.06% 114

Other funds holding ELV

Lehman & Derafelo Financial Resources's ELV Position: Q4 2022 in Review

Lehman & Derafelo Financial Resources held its Elevance Health (ELV) position steady in Q4 2022 at 590 shares worth $303K. The position accounts for 0.09% of the portfolio, ranked #88.

Lehman & Derafelo Financial Resources first reported a position in ELV in Q1 2021 and has held it in 8 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Lehman & Derafelo Financial Resources held 590 shares of Elevance Health worth $303K as of Q4 2022.
  • Lehman & Derafelo Financial Resources left its Elevance Health share count unchanged in Q4 2022.
  • Elevance Health made up 0.09% of Lehman & Derafelo Financial Resources's portfolio in Q4 2022, its #88 holding.
  • Lehman & Derafelo Financial Resources first reported a position in Elevance Health in Q1 2021 and has held it in 8 quarters since.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2022, filed 20 Jan 2023.